Bengaluru-based Indegene, a digital-first, life sciences commercialisation company, has announced the launch of a new centre in Germany, expanding its client-focused consulting and management team in the region.

With this centre, Indegene is further strengthening its presence in Europe to help life sciences companies fast-track digital transformation across the commercialisation value chain. Indegene’s local expert teams will work closely with clients in Germany and across Europe to provide consulting services and healthcare solutions.

Indegene already has a significant presence in Europe, with centres in the UK, Ireland, and Switzerland. In 2019, Indegene acquired DT Associates, a consulting services company in the UK, supporting clients in the healthcare and life sciences space. Indegene supports many leading life sciences clients in the region in a variety of ways across the commercialization value chain.

Medicine spending in Germany is expected to rise from $64.6 billion in 2021 to $76-96 billion at a CAGR of 4.5-7.5% (2022-2026). 

With six operation hubs and 16 offices located across North America, Europe, and Asia, Indegene’s client base includes 19 of the 20 largest biopharmaceutical companies, many emerging biotech companies, and medical device companies.